Publications by authors named "Anja Azanjac"
Article Synopsis
- The study aimed to examine the risk of metabolic syndrome among schizophrenia patients undergoing different antipsychotic therapies: risperidone, clozapine, and aripiprazole, compared to a healthy control group.
- 60 patients with schizophrenia were evaluated using various health metrics, including hormone levels, lipid profiles, and glucose levels, alongside a control group of 20 healthy individuals.
- Results indicated that patients on risperidone and clozapine exhibited significant differences in metabolic markers, highlighting a potentially greater risk for developing metabolic syndrome among these groups compared to those on aripiprazole and healthy controls.
Background: Published data regarding the impact of obesity on COVID-19 outcomes are inconsistent. However, in most studies, body composition was assessed using body mass index (BMI) alone, thus neglecting the presence and distribution of adipose tissue. Therefore, we aimed to investigate the impact of body and visceral fat on COVID-19 outcomes.
View Article and Find Full Text PDF